ISRCTN57556290已完成不适用
A multi-site trial of a novel nutritional supplement (taurine, omega-3 fatty acids, zinc, antioxidants, and lutein) and micro-current stimulation in the treatment of atrophic (dry) age-related macular degeneratio
Atlantic Medical, Inc. (USA)0 个研究点目标入组 80 人开始时间: 2006年12月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Signed written consent
- •2. Between the ages of 50 and 90, inclusive
- •3. Any race or gender
- •4. Diagnosis of nonexudative (dry) Age-related Macular Degeneration (AMD) in at least one eye having more than ten large soft drusen 63 um in diameter, within 3,000 um of the fovea centre, documented on macular exam, retinal angiography and fundus photographs
- •5. Able to understand and comply with the requirements of the trial
- •6. Best Corrected Visual Acuity (BCVA) in the trial eye(s) of 20/32 to 20/125 inclusive as measured by Early Treatment Diabetic Retinopathy Study (ETDRS) (logMAR)
- •7. Subjects must not have conditions that limit the view to the fundus (e.g. vitreous haemorrhage, cataracts, an epiretinal membrane). All subjects with more than or equal to 2+ nuclear opacities and/or significant central opacity (Posterior SubCapsular opacity [PSC] or Anterior SubCapsular opacity [ASC]) more than 1+ will undergo Potential Acuity Meter (PAM) testing. If the vision is more than or equal to two lines improved on PAM over standard acuity measurement then the subject will not be eligible for the trial
- •8. Subjects must be available for a minimum trial duration of approximately six months
- •9. Subjects must agree to take only the nutritional supplement that is provided during this study
- •10. Subjects or eyes must not meet any of the exclusion criteria
排除标准
- •Any of the following excluded a subject from the trial:
- •1. Currently enrolled in an ophthalmic clinical trial
- •2. Eyes with concomitant macular or choroidal disorders other than AMD and with indefinite signs of AMD
- •3. Eyes with a diagnosis of exudative (wet) AMD with active SubRetinal NeoVascularisation (SRNV) or Choroidal NeoVascularisation (CNV) lesions requiring laser photocoagulation in the study eye
- •4. Subjects with significant ocular lens opacities causing vision decrease
- •5. Subjects with amblyopia
- •6. Subjects with optic nerve disease (neuropathy, atrophy, papilledema), unstable glaucoma as defined by intraocular pressures greater than 25 mmHg, three or more glaucoma medications, C/D of 0.8 or greater and visual fields consistent with glaucoma; history of retina-vitreous surgery, degenerative myopia, active posterior intraocular inflammatory disease, chronic use of topical ocular steroid medications, vasoproliferative retinopathies (other than AMD), rhegmatogenous retinal detachment, and inherited macular dystrophies
- •7. Subjects with demand type pacemakers or epilepsy
- •8. Subjects with uncontrolled hypertension (defined as diastolic of 90 or greater and systolic of 150 or greater)
- •9. Subjects with recent history (within the previous year) of cerebral vascular disease manifested with Transient Ischaemic Attacks (TIA?s) or cerebral vascular accidents (CVA?s)
- •10. Subjects with a history of Acquired Immune Deficiency Syndrome (AIDS)
- •11. Subjects who have received any previous experimental procedure in either eye or the use of any investigational drug or treatment within 30 days prior to enrolling in the trial
- •12. Subjects who have had intraocular surgery in trial eye within three months prior to enrolling in the trial
- •13. Smokers or any tobacco use
研究者
相似试验
尚未招募
不适用
Immunomodulatory effects of Fucoidan (seaweed extract) in recreationally active adultsImmune CompetenceInflammatory and Immune System - Normal development and function of the immune systemACTRN12621000872831niversity of Canberra15
已完成
不适用
A study on the effects of a dietary supplement intake on skin in adult female who feel dry skiDry skinJPRN-UMIN000014325Total Technological Consultant Co., Ltd.(TTC)60
已完成
2 期
Prospective randomized trial of nutritional support for esophageal patients after esophagectomyesophageal cancerJPRN-UMIN000018671Osaka Medical Center for Cancer and Cardiovascular Diseases40
招募中
不适用
A four-armed randomised controlled demonstration trial of a multifaceted dietary intervention and probiotic capsules in obese pregnant women in the Counties Manukau Health regioObesityACTRN12615000400561niversity of Auckland220
招募中
2 期
A randomized study to evaluate the effecct of BCAA for preventing skeltal muscle massEsophageal Cancer, nutritional support, NACD004938Esophageal CancerJPRN-jRCTs051220167Kiyoshi Maeda40